Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 8Sarcoma 4Head & Neck 2Genitourinary 2Gastrointestinal 2Dermatologic 2Thoracic 1Other solid neoplasm 1Gynecologic 1Endocrine 1Breast 1

Conditions

Uterine Cervical Neoplasms 182Ovarian Neoplasms 92Carcinoma, Ovarian Epithelial 46Fallopian Tube Neoplasms 35Endometrial Neoplasms 29Peritoneal Neoplasms 23Stomach Neoplasms 18Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Neoplasms 11Vulvar Neoplasms 9Recurrence 9Lung Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Pancreatic Neoplasms 7Locally Advanced Cervical Cancer 7Brenner Tumor 7Uterine Neoplasms 6Testicular Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Neoplasm Metastasis 6Carcinoma 6Urinary Bladder Neoplasms 5Sarcoma 5Colonic Neoplasms 5Breast Neoplasms 5Vaginal Neoplasms 4Triple Negative Breast Neoplasms 4Teratoma 4Small Cell Lung Carcinoma 4

Interventions

trametinib 2dabrafenib 2Temozolomide 2Paclitaxel 2Nivolumab 2Carboplatin 2ulixertinib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1entinostat 1diazepinomicin 1defactinib 1copanlisib 1cobimetinib 1cediranib 1carboxyamido-triazole 1capivasertib 1cabiralizumab 1binimetinib 1adavosertib 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Cisplatin × Gynecologic × Clear all
NCT04851834 2022-12-20

NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma

Xennials Therapeutics Australia Pty Ltd

Phase 1/2 Terminated
12 enrolled
CNSGenitourinaryGynecologic

Urinary Bladder Neoplasms, Glioma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡